- About Us
-
Our Business
-
- Therapeutic Areas Our portfolio is diverse and based upon - Market Research, Regulatory & IP.
- Licensing Licensing activities are excellent opportunities for companies to expand their portfolio.
- Biosimilar Biosimilar are biologic medicines that are developed to match their reference medicine.
-
- CRAM India has grown to be one of the key nations complying GMP manufacturing norms.
- Medical Devices REVA help our clients to deliver customized, cost-effective medical device value chain.
-
API
-
Dosage form
-
-
Operations
- At Reva, we have requisite infrastructure, with a balanced reach across Regulated, Emerging & Expansion markets. And we are committed to helping create healthier communities worldwide through education, outreach and better access to treatment.
-
Research & Development
-
Manufacturing
-
Quality
- Media
- Contact us
Latest News
French drugmaker Sanofi is considering a joint venture or outright sale of its consumer healthcare unit as it readies...
Read More
Read More
MUMBAI: It’s not just import of raw materials (active pharmaceutical ingredients, or APIs) from China that is giving...
Read More
Read More
The Cadila Healthcare stock has corrected over 6 per cent in two days, following the warning Letter from the USFDA for...
Read More
Read More
Home-grown drug firms have 80 per cent of the Rs 1.36 trillion domestic pharmaceuticals market but when it comes to the...
Read More
Read More
New Delhi: The government is actively considering to bring personal hygiene items such as handwash, sanitary napkins,...
Read More
Read More
Regulatory worries dragged down major pharma stocks on Monday, with Glenmark Pharmaceuticals and Aurobindo Pharma...
Read More
Read More
HYDERABAD: Multinational drug company Mylan has said it will invest USD one billion in the next 5-6 years on Capex in...
Read More
Read More
Biocon plans to bring down the cost of insulin to 10 cents (roughly Rs 7) from the $ 5 (Rs 350) currently.
...
Read More
...
Read More
NEW DELHI: The government is set to come up with a list of over-the-counter (OTC) medicines under a separate schedule by...
Read More
Read More
New Delhi: Indian authorities are closely monitoring the sale of heartburn drug Ranitidine after the US drug regulator...
Read More
Read More
HYDERABAD, India: With one-third of the world’s vaccine demand among children shipped from its doors in Hyderabad,...
Read More
Read More
A high-powered commercial delegation from New Jersey, USA led by Governor Philip D. Murphy, former US Ambassador to...
Read More
Read More